Salix Pharmaceuticals (SLXP): Q3 EPS of $0.95 beats by $0.25. Revenue of $185.1M (+26.6% Y/Y)...

|About: Salix Pharmaceuticals, Ltd. (SLXP)|By:, SA News Editor
Salix Pharmaceuticals (SLXP): Q3 EPS of $0.95 beats by $0.25. Revenue of $185.1M (+26.6% Y/Y) misses by $2M. Shares +8.4% AH. (PR)